All Title Author
Keywords Abstract

Impact of obesity and Ala16Val MnSOD polymorphism interaction on lipid, inflammatory and oxidative blood biomarkers

DOI: 10.4236/ojgen.2012.24026, PP. 202-209

Keywords: Ala16Val MnSOD Polymorphism, Obesity, Oxidative Stress, Inflammation, Oxidized LDL, Anti-Oxidized LDL, Hs-PCR

Full-Text   Cite this paper   Add to My Lib


Previous investigations suggest association between obesity and Ala16Val MnSOD gene polymorphism. The V allele produces enzyme which not catalyze the superoxide anion efficiently as occurs with A allele. As obesity is related to development of other metabolic disorders we performed a study that analyzed the effect of interaction between Ala16Val MnSOD polymorphism and obesity on lipid, oxidative and inflammatory biomarkers of adult subjects. The study enrolled 161 volunteers as categorized in six groups with different genotypes: Obeses with different genotypes (AAO, VVO and AVO) and nonobese (AANO, VVNO and AVNO). In general the group AANO presented lower values whereas VVO presented higher values of biomarkers analyzed. These results suggest that oxidative metabolism influenced by genetic status could to minimize or maximize the obesity effects on lipid, oxidative and inflammatory biomarkers that are also implicated in the genesis of important dysfunctions and diseases as atherosclerosis, diabetes 2 and cardiovascular morbidities.


[1]  Valko, M., Rhodes, C.J., Moncol, J., Izakovic, M. and Mazur, M. (2006) Free radicals, metals and antioxidants in oxidative stress induced cancer. Chemico-Biological Interactions, 160, 1-4. doi:10.1016/j.cbi.2005.12.009
[2]  Roberts, C.K. and Sindhu, K.K. (2009) Oxidative stress and metabolic syndrome. Life Sciences, 84, 705-712. doi:10.1016/j.lfs.2009.02.026
[3]  Fridovich, I. (1986) Biologic effects of superoxide radical. Archives of Biochemistry and Biophisics, 247, 1-11. doi:10.1016/0003-9861(86)90526-6
[4]  Christianson, D.W. (1997) Structural chemistry and biology of manganes metalloenzymes. Progress in Biophysics and Moecular Biology, 67, 217-252.
[5]  Lenaz, G. (2001) The mitochondrial production of reactive oxygen species: Mechanisms and implications in human pathology. IUBMB Life, 52, 159-164. doi:10.1080/15216540152845957
[6]  Kim, J.A., Wei, Y. and Sowers, J.R. (2008) Role of mitochondrial dysfunction in insulin resistance. Circulation Research, 102, 401-414.
[7]  Isogawa, A., Yamakado, M., Masao Yano, M. and Shiba, T. (2009) Serum superoxide dismutase activity correlates with the components of metabolic syndrome or carotid artery intima-media thickness. Diabetes Research and Clinical Practice, 86, 213-218. doi:10.1016/j.diabres.2009.09.007
[8]  Karaouzene, N., Merzouk, H., Aribi, M., Merzouk, S.A., Berrouiguet, A.Y., Tessier, C. and Narce, M. (2011) Effects of the association of aging and obesity on lipids, lipoproteins and oxidative stress biomarkers: a comparison of older with young men. Nutrition Metabolic Cardiovascular Disease, 21, 792-799. doi:10.1016/j.numecd.2010.02.007
[9]  Liu, H., Yang, Y., Huang, G., Tan, S. and Liu, Y. (2012) Positive association of pro-inflammatory biomarkers and increased oxidative stress in the healthy elderly. Archives of Gerontology and Geriatrics, 54, e8-e12. doi:10.1016/j.archger.2011.05.016
[10]  Higdon, J.V. and Frei, B. (2003) Obesity and oxidative stress: A direct link to CVD? Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 365-367. doi:10.1161/01.ATV.0000063608.43095.E2
[11]  Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M. and Shimomura, I. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. Journal of Clinical Investigation, 114, 1752-1761. doi:10.1172/JCI21625
[12]  Hauner, H. (2004) The new concept of adipose tissue function. Physiology and Behavior, 83, 653-658. doi:10.1016/j.physbeh.2004.09.016
[13]  Sutton, A., Khoury, H., Prip-Buus, C., Cepanec, C., Pessayre, D. and Degoul, F. (2003) The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics, 13, 145-157. doi:10.1097/00008571-200303000-00004
[14]  Montano, M.A.E., Lera, J.P.B., Gottlieb, M.G.V., Schawnke, C.H.A., Rocha, M.I.U.M., Manica-Cattani, M.F., Santos, G. F. and Cruz, I.B.M. (2009) Association between manganese superoxide dismutase (MnSOD) gene polymorphism and elderly obesity. Molecular Cellular Biochemistry. 328, 33-40. doi:10.1007/s11010-009-0071-z
[15]  Duarte, M.M.F., Duarte, M.M.F., Moresco, R.N., Duarte, T., Santi, A., Bagatini, M.D., Da Cruz, I.B.M., Schetinger, M.R.C. and Loro, V.L. (2010) Oxidative stress in hypercholesterolemia and its association with Ala16Val superoxide dismutase gene polymorphism. Clinical Biochemistry, 43, 1118-1123. doi:10.1016/j.clinbiochem.2010.07.002
[16]  Chen, H., Yu, M., Li, M., Zhao, R., Zhu, Q., Zhou, W., et al. (2012) Polymorphic variations in manganese superoxide dismutase (MnSOD), glutathione peroxidase-1 (GPX1), and catalase (CAT) contribute to elevated plasma triglyceride levels in Chinese patients with type 2 diabetes or diabetic cardiovascular disease. Molecular Cellular Biochemistry. 363, 85-91. doi:10.1007/s11010-011-1160-3
[17]  Jones, D.A., Prior, S.L., Tang, T.S., Bain, S.C., Hurel, S.J., Humphries, S.E., et al. (2010) Association between the rs4880 superoxide dismutase 2 (C > T) gene variant and coronary heart disease in diabetes mellitus. Diabetes Research and Clinical Practice, 90, 196-201. doi:10.1016/j.diabres.2010.07.009
[18]  Mollsten, A., Marklund, S.L., Wessman, M., Svensson, M., Forsblom, C., Parkkonen, M., et al. (2007) A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy. Diabetes, 56, 265-269. doi:10.2337/db06-0698
[19]  Kangas-Kontio, T., Vavuli, S., Kakko, S.J., Penna, J., Savolainen, E.R., Savolainen, M.J. and Liinamaa, M.J. (2009) Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy. British Journal of Ophthalmology, 93, 1401-1416. doi:10.1136/bjo.2009.159012
[20]  Gottlieb, M.G., Schwanke, C.H., Santos, A.F., Jobim, P.F., Denise P. Müssel, D.P., Ivana B.M. and da Cruz, I.B.M. (2005) Association among oxidized LDL levels, SOD2, apolipoprotein E polymorphisms and cardiovascular risk factors in a south Brazilian region population. Genetic Molecular Research, 4, 691-703.
[21]  Montagner, G.F.F., Sagrillo, M., Machado, M.M., Almeida, R.C., Mostardeiro, C.P., Duarte, M.F.F. and Cruz, I.B.M. (2010) Toxicological effects of ultraviolet radiation on lymphocyte cells with different manganese superoxide dismutase Ala16Val polymorphism genotypes. Toxicology in Vitro, 24, 1410-1416. doi:10.1016/j.tiv.2010.04.010
[22]  Montano, M.A.E., Cruz, I.B.M., Duarte, M.M.M.F., Krewer, C.C., Rocha, M.I.U.M., Manica-Cattani, M.F., Soares, F.A.A., Rosa, G., Maris, A.F., Battiston, F.G., Trott, A. and Lera, J.P.B. (2012) Inflammatory cytokines in vitro production are associated with A-la16Val superoxide dismutase gene polymorphism of peripheral blood mononuclear cells. Cytokine, 60, 30-33. doi:10.1016/j.cyto.2012.05.022
[23]  World Health Organization (1988) Obesity: Preventing and managing the global epidemic: Report of a WHO consultation on obesity. WHO Publications, Geneva.
[24]  Bachorik, P.S. and Albers, J.J. (1986) Precipitation methods for quantification of lipoproteins. Methods in Enzymology, 129, 78-100. doi:10.1016/0076-6879(86)29063-1
[25]  Friedewald, W.T., Levy, R.I. and Fredrickson, D.S. (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. Clinical Chemistry, 18, 499-502.
[26]  Jentzsch, A.M., Bachmann, H., Fürst, P. and Biesalski, H.K. (1996) Improved analysis of malondialdehyde in human body fluids. Free Radical Biology and Medicine, 20, 251-256. doi:10.1016/0891-5849(95)02043-8
[27]  Levini, R.L., Garland, D., Oliver, C.N., Amiei, A., Climent, I. and Lenz, A. (1990) Determination of car-bonyl content in oxidatively modified proteins. Methods in Enzymology, 186, 464-468. doi:10.1016/0076-6879(90)86141-H
[28]  Holvoet, P., Stassen, J.M., Van Cleemput, J., Collen, D. and Vanhaecke, J. (1998) Oxidized low density lipoproteins in patients with transplantassociated coronary artery disease. Arterioscleroses, Thrombosis and Vascular Biology, 18, 100-107. doi:10.1161/01.ATV.18.1.100
[29]  Wu, R. and Lefvert, A.K. (1995) Autoantibodies against oxidized low density lipoprotein (OxLDL): Characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL. Clinical and Experimental Immunology, 102, 174-180. doi:10.1111/j.1365-2249.1995.tb06652.x
[30]  Holvoet, P., Kritchevsky, S.B., Tracy, R.P., Mertens, A., Rubin, S.M., Butler, J., Goodpaster, B. and Harris, T.B. (2004) The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the Health, Aging, and Body Composition cohort. Diabetes, 53, 1068-1073. doi:10.2337/diabetes.53.4.1068
[31]  Fonseca, V., Desouza, C., Asnani, S. and Jialal, I. (2004) Nontraditional risk factors for cardiovascular disease in diabetes. Endocrine Reveiws, 25, 153-175. doi:10.1210/er.2002-0034
[32]  Martí, A., Marcos, A. and Martínez, J.A. (2001) Obesity and immune function relationships. Obesity Reveiws, 2, 131-140. doi:10.1046/j.1467-789x.2001.00025.x
[33]  Hotamisligil, G.S. (2006) Inflammation and metabolic disorders. Nature, 444, 860-867. doi:10.1038/nature05485
[34]  Conen, D., Rexrode, K.M., Creager, M.A., Ridker, P.M. and Pradhan, A.D. (2009) Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women: A prospective study. Circulation, 120, 1041-1047. doi:10.1161/CIRCULATIONAHA.109.863092
[35]  De Heredia, F.P., Gómez-Martínez, S. and Marcos, A. (2012) Obesity, inflammation and the immune system. Proceeding of the Nutrition Society, 71 332-338. doi:10.1017/S0029665112000092
[36]  Ozata, M., Mergen, M., Oktenli, C., Aydin, A., Sanisoglu, S.Y., Bolu, E., Yilmaz, M.I., Sayal, A., Isimer, A. and Ozdemir, I.C. (2002) Increased oxidative stress and hypozincemia in male obesity. Clinical Biochemistry, 35, 627-631. doi:10.1016/S0009-9120(02)00363-6
[37]  Burgos Alves, M.I., Avilés Plaza, F., Martínez-Tomás, R., Sánchez-Campillo, M., Larqué, E., Pérez-Llamas, F., Martínez Hernández, P., Parra Pallarés, S. (2010) Oxidized LDL and its correlation with lipid profile and oxidative stress biomarkers in young healthy Spanish subjects. Journal of Physiology Biochemistry, 66, 221-227. doi:10.1007/s13105-010-0028-4
[38]  Augusti, P.R, Ruviaro, A.R., Quatrin, A., Somacal, S., Conterato, G.M., Vicentini, J.T., Duarte, M.M. and Emanuelli, T. (2012) Imbalance in superoxide dismutase/thioredoxin reductase activities in hypercholesterolemic subjects: Relationship with low density lipoprotein oxidation. Lipids in Health and Diseases, 11, 79. doi:10.1186/1476-511X-11-79
[39]  Holvoet, P., De Keyzer, D. and Jacobs Jr., D.R. (2008) Oxidized LDL and the metabolic syndrome. Future Lipidology, 3, 637-649. doi:10.2217/17460875.3.6.637
[40]  Phillips, C.M., Tierney, A.C., Perez-Martinez, P., Defoort, C., Blaak, E.E., Gjelstad, I.M., Lopez-Miranda, J., Kiec-Klimczak, M., Malczewska-Malec, M., Drevon, C.A., Hall, W., Lovegrove, J.A., Karlstrom, B., Risérus, U. and Roche, H.M. (2012) Obesity and body fat classification in the metabolic syndrome: Impact on cardiometabolic risk metabotype. Obesity. doi:10.1038/oby.2012.188
[41]  Bahceci, M., Gokalp, D., Bahceci, S., Tuzcu, A., Atmaca, S. and Arikan, S. (2007) The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? Journal of Endocrinological Investigation, 30, 210-214.
[42]  Ferrari, C.K., Souto, P.C., França, E.L. and Honorio-França, A.C. (2011) Oxidative and nitrosative stress on phagocytes’ function: From effective defense to immunity evasion mechanisms. Archivum Immunologiae et Therapia Experimentalis, 59, 441-448. doi:10.1007/s00005-011-0144-z
[43]  Alvarez, M.N., Trujillo, M. and Radi, R. (2002) Peroxynitrite formation from biochemical and cellular fluxes of nitric oxide and superoxide. Methods in Enzymology, 359, 353-366. doi:10.1016/S0076-6879(02)59198-9
[44]  Denicola, A. and Radi, R. (2005) Peroxynitrite and drugdependent toxicity. Toxicology, 208, 273-288. doi:10.1016/j.tox.2004.11.023


comments powered by Disqus